Novonix Other Stockholder Equity from 2010 to 2025

NVX Stock  USD 1.15  0.14  10.85%   
Novonix Other Stockholder Equity yearly trend continues to be fairly stable with very little volatility. Other Stockholder Equity is likely to outpace its year average in 2025. During the period from 2010 to 2025, Novonix Other Stockholder Equity regression line of annual values had r-squared of  0.29 and arithmetic mean of  129,560,120. View All Fundamentals
 
Other Stockholder Equity  
First Reported
2014-12-31
Previous Quarter
0.0
Current Value
-146.2 K
Quarterly Volatility
5.7 M
 
Yuan Drop
 
Covid
Check Novonix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Novonix's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.8 M, Interest Expense of 3.7 M or Selling General Administrative of 51.5 M, as well as many indicators such as Price To Sales Ratio of 35.32, Dividend Yield of 0.0167 or PTB Ratio of 1.66. Novonix financial statements analysis is a perfect complement when working with Novonix Valuation or Volatility modules.
  
Check out the analysis of Novonix Correlation against competitors.

Latest Novonix's Other Stockholder Equity Growth Pattern

Below is the plot of the Other Stockholder Equity of Novonix Ltd ADR over the last few years. It is Novonix's Other Stockholder Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Novonix's overall financial position and show how it may be relating to other accounts over time.
Other Stockholder Equity10 Years Trend
Slightly volatile
   Other Stockholder Equity   
       Timeline  

Novonix Other Stockholder Equity Regression Statistics

Arithmetic Mean129,560,120
Geometric Mean0.00
Coefficient Of Variation90.85
Mean Deviation106,376,688
Median115,981,810
Standard Deviation117,710,792
Sample Variance13855.8T
Range258.6M
R-Value(0.54)
Mean Square Error10481.8T
R-Squared0.29
Significance0.03
Slope(13,404,618)
Total Sum of Squares207837.5T

Novonix Other Stockholder Equity History

2025116 M
2024110.5 M
202396.1 M
2020-7.5 M
2019 0.23
2017 -0.21
2016null

About Novonix Financial Statements

Novonix investors use historical fundamental indicators, such as Novonix's Other Stockholder Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Novonix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Stockholder Equity110.5 M116 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Novonix Stock Analysis

When running Novonix's price analysis, check to measure Novonix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novonix is operating at the current time. Most of Novonix's value examination focuses on studying past and present price action to predict the probability of Novonix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novonix's price. Additionally, you may evaluate how the addition of Novonix to your portfolios can decrease your overall portfolio volatility.